[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

Year

Day

October 26, 2017
Cancer Care Chronicles

Where Is the Road Map for Glioblastoma?

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3073
Brief Report

Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3168

This biomarker study examines the efficacy of irinotecan plus panitumumab in patients with advanced colorectal cancer whose tumors had high HER3 messenger RNA expression.

JAMA Oncology Clinical Challenge

Hypermetabolic Vocal Cord Focus With Recurrent Oral Cancer History

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3180

A woman in her 80s with a history of recurrent oral cancer was diagnosed with squamous cell carcinoma located at the margin of a palatal graft; surveillance imaging reveals metabolic activity in her left vocal cord. What is your diagnosis?

Comment & Response

Taxane Followed by Anthracycline or Vice Versa: Impact of Sequential Order on Breast Cancer Recurrence?

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3349

Taxane Followed by Anthracycline or Vice Versa: Impact of Sequential Order on Breast Cancer Recurrence?—Reply

Abstract Full Text
JAMA Oncol. Published online October 26, 2017. doi:10.1001/jamaoncol.2017.3352
October 19, 2017
Original Investigation

Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival

Abstract Full Text
has audio
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3326

This cohort study assesses the association of locoregional surgery at diagnosis for small intestine neuroendocrine tumors with survival among Swedish patients.

Brief Report

“Job Lock” Among Long-term Survivors of Childhood CancerA Report From the Childhood Cancer Survivor Study

Abstract Full Text
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3372

This cross-sectional survey study quantifies the prevalence of self-reported “job lock” in a sample of full-time employed childhood cancer survivors and their siblings participating in the Childhood Cancer Survivor Study.

Comment & Response

Brain Metastases in Lung Cancer With Targetable MutationsShould We Allow Targeted Treatment in Prognostic Indices?

Abstract Full Text
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2016.7022

Brain Metastases in Lung Cancer With Targetable Mutations—Reply

Abstract Full Text
JAMA Oncol. Published online October 19, 2017. doi:10.1001/jamaoncol.2017.3375
October 12, 2017
Cancer Care Chronicles

History of Lymphoma

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.2962
Brief Report

HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.3159

This study compared response to ketoconazole treatment among patients with castration-resistant prostate cancer who had 0, 1, or 2 HSD3B1 variant alleles.

Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.3164

This cohort study evaluates whether the HSD3B1 (1245C) allele is associated with worse clinical outcomes from androgen-deprivation therapy for biochemical recurrence after radiotherapy.

Invited Commentary

HSD3B1—A Predictive Biomarker in Advanced Prostate Cancer

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.3158
Comment & Response

All Thiopurines Are Equal but Some Thiopurines Are More Equal Than Others

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.0740

All Thiopurines Are Equal But Some Thiopurines Are More Equal Than Others—Reply

Abstract Full Text
JAMA Oncol. Published online October 12, 2017. doi:10.1001/jamaoncol.2017.3369
October 5, 2017
Brief Report

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant ChemotherapyA Pooled Analysis From 2 Randomized Clinical Trials

Abstract Full Text
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.2899

This pooled analysis of 2 randomized clinical trials evaluates the association of DNA mismatch repair status with disease-free survival in patients with stage III colon cancer treated with FOLFOX.

Comment & Response

Difficulties in Defining and Measuring Cancer-Related Fatigue

Abstract Full Text
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.3355

Difficulties in Defining and Measuring Cancer-Related Fatigue—Reply

Abstract Full Text
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.3358
Poetry and Oncology

A Last Draw From the Boneyard

Abstract Full Text
JAMA Oncol. Published online October 5, 2017. doi:10.1001/jamaoncol.2017.2915
×